
Smith & Nephew plc SNN
$ 31.31
1.23%
Annual report 2025
added 04-18-2026
Smith & Nephew plc Cash and Cash Equivalents 2011-2026 | SNN
Annual Cash and Cash Equivalents Smith & Nephew plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 557 M | 619 M | 302 M | 350 M | 1.28 B | 1.75 B | 257 M | 333 M | 155 M | 38 M | 102 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.75 B | 38 M | 523 M |
Quarterly Cash and Cash Equivalents Smith & Nephew plc
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 1.28 B | - | - | - | 1.75 B | - | - | - | 257 M | - | - | - | 333 M | - | - | - | 155 M | - | - | - | 38 M | - | - | - | 102 M | - | - | - | 65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.75 B | 38 M | 498 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
106 M | $ 13.26 | 1.14 % | $ 1.79 B | ||
|
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | ||
|
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | ||
|
Delcath Systems
DCTH
|
43.5 M | $ 10.67 | 2.79 % | $ 382 M | ||
|
Eargo
EAR
|
101 M | - | - | $ 10.2 M | ||
|
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | ||
|
Second Sight Medical Products
EYES
|
16.2 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
15.3 M | $ 25.74 | 0.12 % | $ 218 M | ||
|
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | ||
|
Helius Medical Technologies
HSDT
|
5.18 M | $ 2.09 | 2.21 % | $ 1.27 M | ||
|
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
24.7 M | $ 3.36 | 1.05 % | $ 126 M | ||
|
Inspire Medical Systems
INSP
|
105 M | $ 57.19 | 1.87 % | $ 1.68 B | ||
|
BioSig Technologies
BSGM
|
20.3 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
636 M | $ 60.47 | 0.62 % | $ 3.3 B | ||
|
ClearPoint Neuro
CLPT
|
45.9 M | $ 11.24 | 0.54 % | $ 318 M | ||
|
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
6.25 M | $ 0.61 | 0.7 % | $ 38 M | ||
|
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | ||
|
IRIDEX Corporation
IRIX
|
6.03 M | $ 1.07 | 3.88 % | $ 18.1 M | ||
|
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | ||
|
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
4.14 M | $ 2.08 | 0.2 % | $ 5.77 M | ||
|
OrthoPediatrics Corp.
KIDS
|
19.6 M | $ 15.41 | 2.32 % | $ 362 M | ||
|
Butterfly Network
BFLY
|
88.8 M | $ 4.89 | 1.98 % | $ 1.04 B | ||
|
Stryker Corporation
SYK
|
4.01 B | $ 307.2 | -2.52 % | $ 117 B | ||
|
TransMedics Group
TMDX
|
488 M | $ 101.25 | 0.46 % | $ 3.44 B | ||
|
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | ||
|
Tandem Diabetes Care
TNDM
|
90.6 M | $ 19.98 | 2.3 % | $ 1.36 B | ||
|
Globus Medical
GMED
|
526 M | $ 90.77 | 0.65 % | $ 12.3 B | ||
|
NanoVibronix
NAOV
|
4.22 M | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
40.8 M | $ 37.22 | 1.53 % | $ 1.16 B | ||
|
Integer Holdings Corporation
ITGR
|
17.2 M | $ 88.24 | -0.31 % | $ 3.07 B | ||
|
Vivos Therapeutics
VVOS
|
2.03 M | $ 0.84 | 4.35 % | $ 8.63 M | ||
|
Edwards Lifesciences Corporation
EW
|
2.94 B | $ 84.0 | 0.6 % | $ 49.1 B | ||
|
LENSAR
LNSR
|
13 M | $ 5.21 | -0.38 % | $ 62.3 M | ||
|
Pulmonx Corporation
LUNG
|
69.8 M | $ 1.33 | 3.52 % | $ 54.1 M | ||
|
MiMedx Group
MDXG
|
166 M | $ 3.57 | 6.25 % | $ 528 M |